Signet Healthcare Partners
Growth equityNew York · Growth–Late Stage · 13 people tracked
Also known as SIGNET HEALTHCARE MANAGEMENT LLC · Signet Healthcare Partners Accredited Partnership · Signet Healthcare Partners QP Partnership
Find your way into Signet Healthcare Partners
643 people in our graph share verified history with the Signet Healthcare Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Signet Healthcare Partners invests growth capital in commercial-stage healthcare companies that are either revenue-generating or preparing for commercial launch, concentrating primarily on the pharmaceutical and medical device sectors. The firm actively partners with management teams to support growth and build successful businesses. Over a 25-year history, it has raised funds with total capital commitments exceeding $600 million and has invested in more than 55 companies globally.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 47 of 61 portfolio companiesBiotech ×34Healthtech ×28Medical Devices ×22Advanced Manufacturing ×11Deep Tech ×8Hardware ×4AI & Machine Learning ×3Consumer ×3
HQs:United States×25Canada×2Switzerland×1Germany×1Denmark×1United Kingdom×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×8
Investments · 61 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12023 · 12022 · 12021 · 22020 · 22016 · 22015 · 213 dated
Ligand is a royalty aggregator that finances late-stage clinical development and commercialization programs for biopharmaceutical companies.
BiotechFintechLa Jolla, US
Brook Byers(Co-founder)inMATTHEW W. FOEHR(Director)JOHN L. HIGGINS(Executive Officer, Director)inMATTHEW KORENBERG(Director)inCHARLES S. BERKMAN(Director)inTodd Davis(Chief Executive Officer)in
Co-investorsSofinnova VenturesVenrock
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
BiotechMalvern, US
Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)inAshley Freidman(Director)
Co-investorsCheckmate Capital Group LLCEssex Woodlands Healthcare PartnersHighCape CapitalOrbiMed1315 CapitalRTW Investments L.P.
Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization.
Advanced ManufacturingBiotechHealthtechMedical DevicesNorth Brunswick, US
Jingjun Huang(Executive Officer, Director)
BoardRobert Bloder(Director)Michael Bogda(Director)inShoufeng Li(Director)Theron Odlaug(Director)
Board seatJames Gale· per SEC Form D
Cerium Pharmaceuticals develops and commercializes medicines for rare or "orphan" diseases, including kidney disease.
BiotechHealthtechGaithersburg, US
Gregg Lapointe(Co-Founder & Chief Executive Officer)inRobert J. Rubin(Co-Founder & Interim CMO)Nancy Klett(Co-Founder & Chief Operating Officer)inŞemsi Burak Derkunt(Chief Scientific Officer)inBrian Schreiber(Chief Medical Officer (2015 to 2021))inPeter Collum(Director)
Board seatJames Gale· per SEC Form D · $10.1M raise · filed Jul 2021
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Board seatJoyce Erony· per SEC Form D · $50M raise · filed Dec 2021
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+5 more
Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.
BiotechHealthtechMedical DevicesSunnyvale, US
David Tierney(Executive Officer, Director)in
BoardSong Toja(Director)William White(Director)Michael Hemric(Director)
Board seatJoyce Erony· per SEC Form D
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Board seatJoyce Erony· per SEC Form D · $60M raise · filed Jan 2021
Co-investorsAmzak HealthAlgerBraidwellEssex Woodlands Healthcare PartnersREDMILESands Capital Ventures
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardWilliam Harrington(Director)
Board seatJoyce Erony· per SEC Form D · $42.8M raise · filed Nov 2020
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+6 more
Advantice is a collective of skin care brands offering science-backed dermatological and wellness products for consumers seeking healthier skin.
ConsumerHealthtechWellness & Fitness
Hellen Spanjer(Head of Innovation)in
Co-investorsTA AssociatesRoundTable Healthcare Partners
Alpex is a research-based pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical products, offering an end-to-end platform covering R&D, formulation, clinical trials, product registration, manufacturing, and global export.
Advanced ManufacturingBiotechHealthtech
Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months.
BiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesLaval, CA
Marie-Hélène Raigneau(Chief Executive Officer)inCatherine Konidas(Chief Administrative Officer)inDr. Beatrice Setnik(Chief Scientific Officer)Dr. Gaetano Morelli(Executive Vice President Medical Affairs, Chief Medical Officer)Steve Mason(Co-Chief Operating Officer)inRobert Sabelli(Co-Chief Operating Officer)in
Co-investorsNovo HoldingsKilmer Group
Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsFountain Healthcare PartnersLongitude CapitalSofinnova Ventures
Curia is a CDMO (Contract Development and Manufacturing Organization) providing drug discovery, development, and manufacturing services across small molecules, generic APIs, sterile drug products, and biologics for biopharma companies.
BiotechEnterprise Software
BiotechSomerset, US
Vithal Dhaduk(Director)Albert Friesen(Executive Officer, Director)Ravishanker Kovi(Executive Officer, Director)in
BoardTheron E. Odlaug(Director)James Gale(Executive Officer)Todd Sone(Director)
Azurity Pharmaceuticals develops and commercializes innovative medicines across 10 therapeutic areas for overlooked patient populations, serving over 50 countries with a portfolio of more than 50 medicines across various dosage forms.
AI & Machine LearningBiotechDigital HealthHealthtechWoburn, US
Avantium develops bio-based materials and polymer technologies, including PEF and other renewable alternatives to conventional plastics, serving the packaging and materials industry.
BiotechCircular EconomyCleantechNew MaterialsNetherlands, NL
Co-investorsNavitas CapitalAster CapitalCapricorn Venture PartnersNV NOMPMVSofinnova Partners+2 more
An online store selling human growth hormone (HGH) injections, peptides, and related products such as Zptropin, Genotropin, Somatropin, Semaglutide, and Ozempic, marketed for bodybuilding, fat loss, and anti-aging.
ConsumerE-commerce
Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules.
BiotechHealthtechPrinceton, US
Gaurav Mehrotra(Executive Officer)inVenkatachalam Krishnan(Executive Officer, Director)Lavesh Samtani(Executive Officer)
BoardJames Gale(Director)Carol S. Ben-Maimon(Director)Richard Van Duyne(Director)
BiotechClearwater, US
TODD R DAVIAU(Executive Officer, Director, Promoter)MARK J LICARDE(Executive Officer, Director, Promoter)BRIAN MCMILLAN(Executive Officer, Director, Promoter)
BoardRONALD L MILLER(Director, Promoter)
Curida is a contract manufacturing organization specializing in pharmaceutical liquid formulations and biologics, operating under strict EU GMP and ISO certifications to ensure product quality and compliance.
Advanced ManufacturingBiotechDeep TechMedical DevicesNorway, NO
Co-investorsCanicaInvestinor
The site presents itself as combining biomass technology with sports-betting infrastructure in Vietnam, but its content is dominated by promotional posts and links for online gambling and card-game platforms (e.g.
Gaming
Perrigo manufactures and distributes branded and private label self-care products including over 13,000 stock keeping units across multiple categories, serving consumers through retailers, pharmacies, and e-commerce channels in the United States, Europe, and other major markets.
ConsumerDirect to ConsumerHealthtechWellness & FitnessPerrigo, Michigan (implied by company name, though not explicitly stated on this page), US
Luther Perrigo
Co-investorsPAG Japan
Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.
BiotechHealthtechMedical DevicesMalvern, US
Blaise Coleman(President; Chief Executive Officer)inMatthew Maletta(Executive Vice President; Chief Legal Officer; Secretary)inFrank Raciti(Vice President; Controller; Chief Accounting Officer)inMark Bradley(Executive Vice President; Chief Financial Officer)inScott Hirsch(Director)Paul Efron(Director)
Medtronic designs and develops medical technology for treating complex diseases.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investors8VCCWRU Technology VenturesElevate VenturesMenlo VenturesOak Investment PartnersPfizer Venture Investments+5 more
Clario provides endpoint technologies and software for clinical trial management, serving pharmaceutical and biotech sponsors, CROs, and clinical trial sites globally.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAlpine MeridianGenstar
Flerie invests in and builds companies working on pharmaceutical and biotech projects or adjacent capabilities, using its network, expertise, and resources to support their growth.
BiotechHealthtech
BiotechDeep TechHardware
Co-investorsClaremont Creek VenturesMission Bay CapitalMission Biocapital
GBI Biomanufacturing manufactures stem cells for regenerative medicine applications, including treatments for orthopedic injuries, wound care, and arthritic conditions.
BiotechDeep TechHealthtechMedical DevicesFlorida, US
Jesse McCool(President)in
BoardKarl Pinto(Chair of the Board of Directors)
Juno Pharma Canada Inc. is a pharmaceutical company formed in April 2025 through the merger of Juno Pharmaceuticals Corp. and Omega Laboratories Limited.
BiotechMontreal, CA
LAXAI Life Sciences is a Contract Research, Development, and Manufacturing Organization (CRDMO) offering small molecule R&D, custom synthesis, process development, scale-up, and manufacturing of specialty chemicals, intermediates, and APIs.
Advanced ManufacturingBiotechHealthtech
Vamsi Maddipatla(Chairman and Managing Director)
Leon develops nanoparticle-based drug delivery systems for therapeutic applications in healthcare.
Advanced ManufacturingBiotechDeep TechMedical DevicesPlanegg, DE
Dr. Wolfgang Hofmann(Chief Executive Officer)Dr. Blerina Shkodra(Chief Scientific Officer)Dr. Matthias Schumacher(Chief Technology Officer)in
Co-investorsLBBW Venture Capital GmbH
Following a 2025 merger of Mallinckrodt and Endo, the combined business separated into two companies: Keenova Therapeutics, which develops treatments for rare, stigmatized, or unaddressed conditions across areas such as immunology, urology, hepatology, ophthalmology, orthopedics, and critical care; and Par Health, which produces generics, sterile injectables, and active pharmaceutical ingredients backed by a U.S.-based manufacturing network.
Advanced ManufacturingBiotechHealthtechMedical Devices
Co-investorsARCH Venture PartnersCross Creek AdvisorsPfizer Venture InvestmentsSofinnova Ventures
Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.
BiotechConstruction TechHealthtechUK, GB
JIM CAUSEY(Executive Officer)PETER RULE(Executive Officer, Director)inPATRICK NUGENT(Executive Officer)DONALD WEBBER(Executive Officer)
BoardADITYA PURI(Director)KENNETH ABRAMOWITZ(Director)
Co-investorsAscension VenturesBioBrit
PainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery.
Deep TechHealthtechMedical DevicesTampa, US
Shanth(Chief Executive Officer)
Co-investorsWindham Capital Partners
Paragonix Technologies develops, manufactures, and services organ preservation devices that combine cooling techniques with digital tracking and monitoring for clinicians managing donor organs during transplantation.
HardwareHealthtechMedical DevicesCambridge, US
DeWitt Davenport(Director)John Cammett(Director)Carl Rickenbaugh(Director)Alexander Arrow(Director)John McDermott(Director)Lisa Anderson(Executive Officer, Director)
RK Pharma Inc is a US-based generic pharmaceutical group that develops, manufactures, and sells generic drugs, active pharmaceutical ingredients, and injectable, sterile ophthalmic, and dermal products, with a focus on formulation-challenged and first-generic opportunities.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtechNew Jersey, US
Nailesh Bhatt(Founder and CEO of VGYAAN Pharmaceuticals)
Sancilio & Company provides guidance and regulatory support to early-stage biopharmaceutical entrepreneurs on compliance, manufacturing, and funding strategy.
BiotechRiviera Beach, US
Frederick Sancilio(Executive Officer, Director)inDaren Graham(Executive Officer)Andrew Folmer(Executive Officer)Stephen Porter(Executive Officer)
BoardDennis Langer(Director)Patrick Gray(Director)
SmartMedSys develops G-EYE, a colonoscopy technology that improves polyp removal efficiency and adenoma detection compared to standard procedures.
HealthtechMedical DevicesRa'anana, IL
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Pharmaceutics InternationalArgostherapeuticsClarislifesciencesHydrolixImpopharmaKewincMolecularmedNorthX BiologicsNxbioOctoplusPharmanobisRK PharmaSpepharmTeligentVigenebio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 9
2 IPOs · 7 acquisitions · showing 8LigandNASDAQ: LGNDTELA BioNASDAQ: TELAGynesonicsacq. by HologicArborpharmaacq. by Azurity PharmaceuticalsElanacq. by PerrigoEpix Therapeuticsacq. by MedtronicFluxionacq. by Cell MicrosystemsGi Supplyacq. by Laborie
Portfolio news
latest coverage across their companiesLigand · investing.com · Sep 9, 2026
Avantium · finance.yahoo.com · Aug 19, 2026
TELA Bio · investing.com · Aug 10, 2026
Leon Nanodrugs · munich-startup.de · Feb 19, 2026
PainTEQ · pulse2.com · Aug 30, 2025
Elan · elanfinancialservices.com · Aug 5, 2025
Frequently asked questions
- How many investments has Signet Healthcare Partners made?
- Signet Healthcare Partners has 61 tracked investments, 9 of which have exited, including 2 dated in the last 24 months.
- What stage does Signet Healthcare Partners invest at?
- Signet Healthcare Partners invests at the Growth, Late Stage stages.
- What is Signet Healthcare Partners's typical check size?
- Signet Healthcare Partners typically writes checks of $10M – $50M.
- What sectors does Signet Healthcare Partners focus on?
- Signet Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Signet Healthcare Partners located?
- Signet Healthcare Partners is headquartered in New York, US.
- Does Signet Healthcare Partners lead rounds?
- Yes, Signet Healthcare Partners leads investment rounds.
- Who does Signet Healthcare Partners co-invest with?
- Signet Healthcare Partners most often shares deals with Pfizer Venture Investments, Sofinnova Ventures, 8VC, among 51 tracked co-investors.
Co-investors · 5
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
APERTURE Venture Partners is a venture capital firm investing $1-5 million in early-stage companies focused on healthcare and healthy living sectors, with a geographic preference for the Northeast and West Coast.
Firms observed investing alongside Signet Healthcare Partners, from public investor directories. Shared companies are the overlap with Signet Healthcare Partners's recorded portfolio.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.